Zoetis Inc (NYSE:ZTS)

82.79
Delayed Data
As of 4:03pm ET
 +2.03 / +2.51%
Today’s Change
52.25
Today|||52-Week Range
82.93
+14.92%
Year-to-Date
Chart of the Day: Is Campbell Soup in a Death Spiral?
Feb 16 / TheStreet.com - Paid Partner Content
Zoetis (ZTS) Q4 Earnings & Revenues Surpass Estimates
Feb 15 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Beats on Q4 Earnings & Sales, Gives 2018 View
Feb 15 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Warming Up to Q4 Earnings: What's in Store?
Feb 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close80.76
Today’s open81.17
Day’s range81.00 - 82.93
Volume2,697,182
Average volume (3 months)2,613,747
Market cap$39.2B
Data as of 4:03pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+6.06%
Earnings growth (this year)+25.92%
Earnings growth (next 5 years)+14.90%
Revenue growth (last year)+8.57%
P/E ratio47.3
Price/Sales6.69
Price/Book22.18

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+4.34+3.79%
BAXBaxter International...+0.93+1.38%
INCYIncyte Corp+2.61+3.06%
VRTXVertex Pharmaceutica...+8.31+5.27%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$0.66
Annual revenue (last year)$5.3B
Annual profit (last year)$864.0M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
New Jersey, New Jersey

Forecasts